AdherenceNCT07644780
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients Supplements
A study testing Implementation Approaches in people with Adherence and Pregnancy, run by Nutrition International at 3 sites in Nigeria.
Trial summary
In collaboration with the Federal Government of Nigeria and Bauchi State, Nutrition International (NI) conducted a three-year implementation research study to assess whether adherence solutions - developed through a human-centered designed (HCD) approach - could improve adherence to multiple micronutrient… Read more about this study
- Who is it for?
- Ages 15 years and older, women onlyHealthy volunteers can take part
- What is being tested?
- Implementation Approaches
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,601 participants
- Where
- 3 sitesNigeria
- Study dates
- 7 Mar 2024to 26 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 years and older
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Pregnant/post-partum women
- Women of reproductive age (15-49 years of age)
- Pregnant or up to 3 months post-partum women
- Having reportedly received at least one MMS bottle at least 30 days before start of data collection from a participating public health facility-
- Provide consent for participation
- Health Care Workers (HCWs)
Show all 9Show fewer
- HCWs providing ANC services including MMS and IFAs to pregnant women at the selected health facilities
- Husbands
- Husbands of the enrolled pregnant women At endline, the same criteria apply.
Who cannot join
- Anemic pregnant women
Trial locations and contacts
3 sites in 1 country.
Nigeria3 sites
Public health facilities in Dass
Dass, Bauchi
Public health facilities in Ganjuwa
Ganjuwa, Bauchi
Public health facilities in Giade
Giade, Bauchi
About this study
In collaboration with the Federal Government of Nigeria and Bauchi State, Nutrition International (NI) conducted a three-year implementation research study to assess whether adherence solutions - developed through a human-centered designed (HCD) approach - could improve adherence to multiple micronutrient supplementation (MMS) among pregnant women in Nigeria. These set of adherence solutions focused on strengthening the capacity of healthcare workers and community members, improving nutrition counselling within antenatal care, and engaging pregnant women' family members to support consistent MMS intake.
Read the detailed description
Research has shown that antenatal multiple micronutrient supplementation (MMS), a daily dose of 15 vitamins and minerals, is just as effective as iron and folic acid supplementation (IFAS) in preventing maternal anaemia, more effective at improving birth outcomes and is safe for mothers and babies.
In 2020, the World Health Organization (WHO) released an updated guidance recommending that implementation research (IR) be conducted in settings where the transition from IFAS to MMS is being considered in low- and middle- income countries. IR can help countries understand how to best design and implement effective intervention in real-life settings and can be used to identify and investigate challenges that prevent effective implementation.
In line with the WHO's recommendation, in 2021, the Nigeria Federal Ministry of Health approved the use of MMS during pregnancy and called for implementation research (IR) in the updated National Guidelines for the Prevention and Control of Micronutrient Deficiencies in Nigeria.
Based on national stakeholders' identification of a critical need for context-specific implementation evidence, efforts focused on understanding how MMS can be effectively delivered, accepted, and adhered to within the Nigerian health system, particularly in light of the implementation bottlenecks and adherence gaps previously documented in IFAS programs.
This IR project aims to evaluate implementation approaches on optimizing pregnant women's adherence to MMS. One of the components of this IR project is an outcome evaluation - the focus of this protocol - that seeks to answer the following research questions:
Primary research questions:
- Does implementation of these implementation approaches increase pregnant women's adherence to MMS?
Secondary research questions:
- Are the implementation approaches acceptable to key stakeholders?
- Does implementation of the implementation approaches increase the quality of care/nutrition counseling in ANC?
The implementation approaches focused on:
- Strengthening the capacity building of healthcare workers and community members
- Improving nutrition counselling integrated into ANC delivery with an emphasis on MMS adherence
- Engaging pregnant woman's family members (husbands) and influential community members to support maternal health and nutrition
An outcome evaluation was completed using a cluster randomized controlled trial (cRCT) with cross-sectional baseline (prior to the introduction of the implementation approaches) and endline (approximately 2 years after the introduction of the introduction of the implementation approaches) surveys among pregnant women, their husbands and healthcare workers (HCWs) across the three Local Government Areas (LGAs) in Bauchi State. MMS was integrated into routine ANC across the state prior to the baseline assessment.
Nutrition International worked closely with the Bauchi state government to select 3 LGAs (Dass, Ganjuwa and Giade) representing the north, central and southern parts of the state. This decision was made taking into consideration state representation key criteria such as religious demographic, ANC attendance, security, IFA utilization and socio-economic distribution. These LGAs comprise a total of 42 wards all of which were designated as study clusters for the intervention and control arms. Out of these 42 wards, a simple random selection was used to randomly allocate 22 wards to the intervention arm and 20 to the control arm across the three target LGAs:
- Control arm: Eligible pregnant women in these study sites receive MMS as part of their standard ANC.
- Intervention arm: Eligible pregnant women in these study sites receive MMS alongside the implementation approaches as part of their standard ANC.
A third observational arm was selected from a separate LGA where MMS had not been introduced and IFAS continued to be the standard of care to help contextualise differences between the intervention and control arms.
Quantitative and qualitative data were collected from participants through interviewer-administered questionnaires and focus group discussions. The study measured adherence through several methods including self-reported daily consumption, average consumption rate over a three-month period, and a physical pill count by the data collector. Difference-in-difference analysis will be used to assess whether the implementation approaches increased MMS adherence at endline. Descriptive statistics will be used to determine whether the adherence solutions are acceptable to healthcare workers, pregnant women, and their husbands.
- Being tested
- Implementation Approaches
- Keywords
- MMS, Adherence, Antenatal care, maternal supplementation, Nigeria, maternal nutrition, pregnant women, implementation research, ANC, Multiple Micronutrient Supplementation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Implementation ApproachesBehavioural
Implementation approaches are human-centered designed strategies aimed at optimizing pregnant women's daily adherence to MMS.
| Study group | Role | What they receive |
|---|---|---|
| Control arm | No intervention | Not described |
| Intervention Arm | Experimental | Eligible pregnant women received implementation approaches Receives: Behavioral: Implementation Approaches |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adherence to MMS
Defined as "when pregnant women consume the right dose of multiple micronutrient supplementation (MMS) at the right time throughout pregnancy".
Measured through self-reported daily consumption, self-reported average consumption rate over a three-month period, and pill count.
Measured: At baseline and approximately 2 years after (endline)
Secondary outcomes (1)
Acceptability
Defined as stakeholders' attitude towards MMS and its introduction as part of ANC. Assessed through surveys (Likert scale).
The Likert scale is a 5 point scale quantifying attitudes from "strongly agree" to "strongly disagree".
Measured: At baseline and approximately 2 years after (endline)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2026
- Study start7 Mar 2024
- Primary completion26 May 2025
- Study completion26 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AdherenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 2,601 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nutrition International
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Babajide Adebisi, Principal investigator, Nutrition InternationalJennifer Busch Hallen, Principal investigator, Nutrition International
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07644780
- Sponsor's protocol ID
- NI-07-2023-MMSN
- Status last verified
- Jun 2026
- First submitted
- 14 Jan 2025
- Last updated
- 12 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Published IPD will be shared upon reasonable request
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients Supplements
- ClinicalTrials.gov ID
- NCT07644780
- Acronym / sponsor ID
- NI-07-2023-MMSN
- Keywords
- MMS, Adherence, Antenatal care, maternal supplementation, Nigeria, maternal nutrition, pregnant women, implementation research
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 2,601 participants (actual)
- Lead sponsor
- Nutrition InternationalUniversity, hospital or other
- Study start
- 7 Mar 2024 (actual)
- Primary completion
- 26 May 2025 (actual)
- Study completion
- 26 May 2025 (actual)
- First posted
- 12 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In collaboration with the Federal Government of Nigeria and Bauchi State, Nutrition International (NI) conducted a three-year implementation research study to assess whether adherence solutions - developed through a human-centered designed (HCD) approach - could improve adherence to multiple micronutrient supplementation (MMS) among pregnant women in Nigeria. These set of adherence solutions focused on strengthening the capacity of healthcare workers and community members, improving nutrition counselling within antenatal care, and engaging pregnant women' family members to support consistent MMS intake.
Detailed description
Research has shown that antenatal multiple micronutrient supplementation (MMS), a daily dose of 15 vitamins and minerals, is just as effective as iron and folic acid supplementation (IFAS) in preventing maternal anaemia, more effective at improving birth outcomes and is safe for mothers and babies.
In 2020, the World Health Organization (WHO) released an updated guidance recommending that implementation research (IR) be conducted in settings where the transition from IFAS to MMS is being considered in low- and middle- income countries. IR can help countries understand how to best design and implement effective intervention in real-life settings and can be used to identify and investigate challenges that prevent effective implementation.
In line with the WHO's recommendation, in 2021, the Nigeria Federal Ministry of Health approved the use of MMS during pregnancy and called for implementation research (IR) in the updated National Guidelines for the Prevention and Control of Micronutrient Deficiencies in Nigeria.
Based on national stakeholders' identification of a critical need for context-specific implementation evidence, efforts focused on understanding how MMS can be effectively delivered, accepted, and adhered to within the Nigerian health system, particularly in light of the implementation bottlenecks and adherence gaps previously documented in IFAS programs.
This IR project aims to evaluate implementation approaches on optimizing pregnant women's adherence to MMS. One of the components of this IR project is an outcome evaluation - the focus of this protocol - that seeks to answer the following research questions:
Primary research questions:
- Does implementation of these implementation approaches increase pregnant women's adherence to MMS?
Secondary research questions:
- Are the implementation approaches acceptable to key stakeholders?
- Does implementation of the implementation approaches increase the quality of care/nutrition counseling in ANC?
The implementation approaches focused on:
- Strengthening the capacity building of healthcare workers and community members
- Improving nutrition counselling integrated into ANC delivery with an emphasis on MMS adherence
- Engaging pregnant woman's family members (husbands) and influential community members to support maternal health and nutrition
An outcome evaluation was completed using a cluster randomized controlled trial (cRCT) with cross-sectional baseline (prior to the introduction of the implementation approaches) and endline (approximately 2 years after the introduction of the introduction of the implementation approaches) surveys among pregnant women, their husbands and healthcare workers (HCWs) across the three Local Government Areas (LGAs) in Bauchi State. MMS was integrated into routine ANC across the state prior to the baseline assessment.
Nutrition International worked closely with the Bauchi state government to select 3 LGAs (Dass, Ganjuwa and Giade) representing the north, central and southern parts of the state. This decision was made taking into consideration state representation key criteria such as religious demographic, ANC attendance, security, IFA utilization and socio-economic distribution. These LGAs comprise a total of 42 wards all of which were designated as study clusters for the intervention and control arms. Out of these 42 wards, a simple random selection was used to randomly allocate 22 wards to the intervention arm and 20 to the control arm across the three target LGAs:
- Control arm: Eligible pregnant women in these study sites receive MMS as part of their standard ANC.
- Intervention arm: Eligible pregnant women in these study sites receive MMS alongside the implementation approaches as part of their standard ANC.
A third observational arm was selected from a separate LGA where MMS had not been introduced and IFAS continued to be the standard of care to help contextualise differences between the intervention and control arms.
Quantitative and qualitative data were collected from participants through interviewer-administered questionnaires and focus group discussions. The study measured adherence through several methods including self-reported daily consumption, average consumption rate over a three-month period, and a physical pill count by the data collector. Difference-in-difference analysis will be used to assess whether the implementation approaches increased MMS adherence at endline. Descriptive statistics will be used to determine whether the adherence solutions are acceptable to healthcare workers, pregnant women, and their husbands.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control arm | No intervention | – |
| Intervention Arm | Experimental | Behavioral: Implementation ApproachesEligible pregnant women received implementation approaches |
Who may qualify
- Ages
- 15 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (9 listed)
- Pregnant/post-partum women
- Women of reproductive age (15-49 years of age)
- Pregnant or up to 3 months post-partum women
- Having reportedly received at least one MMS bottle at least 30 days before start of data collection from a participating public health facility-
- Provide consent for participation
Key exclusion criteria (1 listed)
- Anemic pregnant women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Implementation ApproachesImplementation approaches are human-centered designed strategies aimed at optimizing pregnant women's daily adherence to MMS. | Behavioural | Intervention Arm |
Primary outcome
Adherence to MMS
Time frame: At baseline and approximately 2 years after (endline)
Defined as "when pregnant women consume the right dose of multiple micronutrient supplementation (MMS) at the right time throughout pregnancy". Measured through self-reported daily consumption, self-reported average consumption rate over a three-month period, and pill count.
1 secondary outcome
Acceptability
Time frame: At baseline and approximately 2 years after (endline)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2026.
- Individual participant dataSharing planned: Yes. Published IPD will be shared upon reasonable request
Related trials for Adherence
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Active, not recruitingObservational study
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Primary Hypercholesterolemia, Mixed Dyslipidemia
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Not yet recruiting
Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise
Treatment Adherence and Compliance, Resistance Exercise
Recruiting
Hybrid mHealth and Telerehabilitation vs Conventional Physiotherapy for Subacromial Pain Syndrome
Subacromial Pain Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Babajide Adebisi principal investigator
Nutrition International
Jennifer Busch Hallen principal investigator
Nutrition International
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Implementation Approaches in people with Adherence and Pregnancy, run by Nutrition International at 3 sites in Nigeria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adherence to MMS (time frame: At baseline and approximately 2 years after (endline)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.